Table 5.
Negative effects of COVID-19 between countries having doses of vaccine below or above the optimal (estimated) level, used as cut-off point.
| Scenario A | Scenario B | Scenario C | ||
|---|---|---|---|---|
| Variables | Below or above the cut-off point = optimal level (estimated) | *Optimal level in March 2021 (Initial phase of pandemic) Doses of vaccines per 100 inhabitants = 46.8* Average value |
*Optimal level in May 2021 (Maturity phase of pandemic) Doses of vaccines per 100 inhabitants = 90* Average value |
*Optimal level over March–May 2021 (Evolution of COVID-19 pandemic) Doses of vaccines per 100 inhabitants = 80.5* Average value |
| Confirmed Cases/population % | Below | 4.15 | 3.88 | 3.82 |
| Above | 5.94 | 8.41 | 7.74 | |
| Case Fatality Ratios (CFR) % | Below | 1.94 | 1.84 | 1.86 |
| Above | 0.50 | 0.47 | 0.75 | |
| Mortality per 100 000 people | Below | 75.00 | 67.93 | 67.90 |
| Above | 32.74 | 41.11 | 63.20 | |
| Population | Below | 65 495 630.45 | 51 009 497.76 | 51 777 286.42 |
| Above | 6 401 920.67 | 6 401 920.67 | 6 642 840.00 |